GMAT Question of the Day - Daily to your Mailbox; hard ones only

It is currently 19 Mar 2019, 20:12

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Close

Request Expert Reply

Confirm Cancel

A large pharmaceutical firm recently introduced a newer version of its

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:

Hide Tags

 
Manager
Manager
User avatar
S
Joined: 10 Apr 2018
Posts: 69
Location: India
Concentration: Entrepreneurship, Strategy
Schools: ISB '20 (D), NUS '21
GMAT 1: 650 Q48 V31
GMAT 2: 680 Q48 V34
GPA: 3.3
Premium Member Reviews Badge
A large pharmaceutical firm recently introduced a newer version of its  [#permalink]

Show Tags

New post 25 Feb 2019, 03:55
00:00
A
B
C
D
E

Difficulty:

  35% (medium)

Question Stats:

75% (01:55) correct 25% (02:14) wrong based on 44 sessions

HideShow timer Statistics

A large pharmaceutical firm recently introduced a newer version of its . The new product is identical to the basic version except that it includes an ingredient to alleviate nausea, the most common side effect of the basic remedy. However, during the first six months that both products were on the market, the company sold more than six times as much of the basic remedy as it did of the newer version. The pharmaceutical company therefore decided that avoiding side effects was not the primary consideration of customers who bought its headache remedies.

Which of the following, if true, would most call into question the pharmaceutical company's conclusion?


A. The pharmaceutical company sells its headache remedies to hospitals and clinics as well as to retail distributors.

B. Customers who buy headache remedies made by this firm also buy other pharmaceutical products that cause minor side effects.

C. The new headache remedy and the basic headache remedy both cause side effects other than nausea in less than 1 percent of all users.

D. Because of the risk of unknown or unexpected side effects, many customers avoid new pharmaceutical products until they have been proven to be safe over time.

E. No significant difference in price exists between the new headache remedy and the basic headache remedy.

_________________

If my post was helpful, kindly contribute a Kudos.

Director
Director
User avatar
P
Joined: 20 Sep 2016
Posts: 630
Location: India
Concentration: Strategy, Operations
GPA: 3.95
WE: Operations (Real Estate)
GMAT ToolKit User
Re: A large pharmaceutical firm recently introduced a newer version of its  [#permalink]

Show Tags

New post 25 Feb 2019, 06:24
A large pharmaceutical firm recently introduced a newer version of its . The new product is identical to the basic version except that it includes an ingredient to alleviate nausea, the most common side effect of the basic remedy. However, during the first six months that both products were on the market, the company sold more than six times as much of the basic remedy as it did of the newer version. The pharmaceutical company therefore decided that avoiding side effects was not the primary consideration of customers who bought its headache remedies.

Understand :
new prod = basic prod
ONLY new prod reduces MOST COMMON SIDE effect of the basic
fist 6 months stats : new prod sold = x ...basic prod = 6x

conclsuin : avoiding side effect = NOT primary

Think : In what sitaution will the ppl choose basic prod even if their primary consideration is avoiding side effects !!
Now the argument says avoids the MOST COMMON SIDE EFFECT...but what if the new prod actually worsens one of the other side effects??? or gives rise to a new side effect??? what if the new ingreduent" actually has some neative result too ??
Then even though the primary consideration is acoiding nausea , the ppl may be scared of the above avg pain suffered from other side effefects???

Weaken framework : We want an answer choice which would tell us the PRIMARY CONSIDERATION may actually be acoiding side effects BUT still ppl chose basic !!

Which of the following, if true, would most call into question the pharmaceutical company's conclusion?


A. The pharmaceutical company sells its headache remedies to hospitals and clinics as well as to retail distributors.
- Irrelevant

B. Customers who buy headache remedies made by this firm also buy other pharmaceutical products that cause minor side effects.
-Other prods : out o scipe

C. The new headache remedy and the basic headache remedy both cause side effects other than nausea in less than 1 percent of all users.
- SO?? read the framewrok !! do we get an answer??

Quote:
D. Because of the risk of unknown or unexpected side effects, many customers avoid new pharmaceutical products until they have been proven to be safe over time.
- This hingesupon ppls ears !!! so even if ppl want t avoid side effects what if they are scared of even worse or other side effects of the new prod before ppl are sure that new is good !!! This gives us AN ALTERNATE casue !!!


E. No significant difference in price exists between the new headache remedy and the basic headache remedy.[/quote]
- price : irrelevant !!
GMAT Club Bot
Re: A large pharmaceutical firm recently introduced a newer version of its   [#permalink] 25 Feb 2019, 06:24
Display posts from previous: Sort by

A large pharmaceutical firm recently introduced a newer version of its

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  


Copyright

GMAT Club MBA Forum Home| About| Terms and Conditions and Privacy Policy| GMAT Club Rules| Contact| Sitemap

Powered by phpBB © phpBB Group | Emoji artwork provided by EmojiOne

Kindly note that the GMAT® test is a registered trademark of the Graduate Management Admission Council®, and this site has neither been reviewed nor endorsed by GMAC®.